Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,637 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer.
Amiri-Kordestani L, Blumenthal GM, Xu QC, Zhang L, Tang SW, Ha L, Weinberg WC, Chi B, Candau-Chacon R, Hughes P, Russell AM, Miksinski SP, Chen XH, McGuinn WD, Palmby T, Schrieber SJ, Liu Q, Wang J, Song P, Mehrotra N, Skarupa L, Clouse K, Al-Hakim A, Sridhara R, Ibrahim A, Justice R, Pazdur R, Cortazar P. Amiri-Kordestani L, et al. Among authors: hughes p. Clin Cancer Res. 2014 Sep 1;20(17):4436-41. doi: 10.1158/1078-0432.CCR-14-0012. Epub 2014 May 30. Clin Cancer Res. 2014. PMID: 24879797 Clinical Trial.
First FDA approval of dual anti-HER2 regimen: pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer.
Blumenthal GM, Scher NS, Cortazar P, Chattopadhyay S, Tang S, Song P, Liu Q, Ringgold K, Pilaro AM, Tilley A, King KE, Graham L, Rellahan BL, Weinberg WC, Chi B, Thomas C, Hughes P, Ibrahim A, Justice R, Pazdur R. Blumenthal GM, et al. Among authors: hughes p. Clin Cancer Res. 2013 Sep 15;19(18):4911-6. doi: 10.1158/1078-0432.CCR-13-1212. Epub 2013 Jun 25. Clin Cancer Res. 2013. PMID: 23801166
Microbial Risk in Pharmaceutical Manufacturing and ICH Q9.
Guilfoyle DE, Friedman RL, Hughes PF, Hussong D, Rosenberg AS, Brorson K. Guilfoyle DE, et al. PDA J Pharm Sci Technol. 2013 Mar-Apr;67(2):79-80. doi: 10.5731/pdajpst.2013.00915. PDA J Pharm Sci Technol. 2013. PMID: 23569069 No abstract available.
Emerging concepts of CMV in transplantation.
Westall GP, Gottlieb D, Hughes P, Marinelli T, Rawlinson WD, Ritchie D, Sasadeusz J, Yong MK. Westall GP, et al. Among authors: hughes p. Intern Med J. 2024 Dec 2. doi: 10.1111/imj.16587. Online ahead of print. Intern Med J. 2024. PMID: 39620697 Review.
Examining naloxone access and interest in secondary naloxone distribution on an American Indian Reservation in the Northern Midwest of the United States.
Schneider KE, Allen ST, O'Rourke A, Reid MC, Conrad M, Hughes P, Palombi L, Wakemup T, Medley A, Walls M. Schneider KE, et al. Among authors: hughes p. Drug Alcohol Depend Rep. 2024 Oct 5;13:100285. doi: 10.1016/j.dadr.2024.100285. eCollection 2024 Dec. Drug Alcohol Depend Rep. 2024. PMID: 39498371 Free PMC article.
1,637 results